BXP, Inc. (BXP)
NYSEReal EstateReit - OfficeSnapshot 2026-07-08
$66.78-2.64%
Close 2026-07-08 · 1-day change
Reading BXP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BXP free→NYSEReal EstateReit - OfficeSnapshot 2026-07-08
Reading BXP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BXP free→QuarterlyIQ Insights · BXP
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $66.78. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $69 BXP trades at 8.8× p/ffo, below its 16× p/ffo peer median, but our blended $60 fair value sits below the price. We hold it with medium confidence: the peer anchor overstates how cheap it looks. Analysts target $61–$81. Note: our $60 fair value sits below the entire analyst range ($61–$81). Not investment advice.
$61.00 – $81.00 (median $66.50) · 10 analysts · as of 2026-07-06
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $66.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $16.98 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $8.98 | — | — | TTM | high |
| graham number | 12M | $39.51 | — | — | TTM | high |
| Mgmt guidance | 12M | $34.94 | 15.7 | 2.22 | Mgmt | high |
| Peer P/FCF | 12M | $61.09 | 20.9 | 2.93 | TTM | high |
| Peer P/FFO | 12M | $122.41 | 15.7 | 7.78 | TTM | high |
| Peer P/S | 12M | $170.39 | 7.8 | 21.94 | TTM | high |
| PEG | 12M | $41.59 | 28.7 | 1.45 | TTM | high |
| residual income | 12M | $37.25 | — | — | TTM | high |
| Own P/E history | 12M | $63.52 | 43.8 | 1.45 | TTM | high |
| triangulated | 12M | $24.30 | 15.7 | 1.54 | Triangulated | high |
| Mgmt guidance | 3Y | $72.39 | 15.7 | 4.60 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $32.55 | 20.9 | 1.56 | Hist. CAGR(prov.) | medium |
| Peer P/FFO | 3Y | $97.26 | 15.7 | 6.18 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $178.71 | 7.8 | 23.01 | Analyst | medium |
| PEG | 3Y | $99.02 | 28.7 | 3.45 | Analyst | medium |
| Own P/E history | 3Y | $151.23 | 43.8 | 3.45 | Analyst | medium |
| Mgmt guidance | 5Y | $117.64 | 15.7 | 7.48 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $21.39 | 20.9 | 1.02 | Hist. CAGR(prov.) | high |
| Peer P/FFO | 5Y | $83.44 | 15.7 | 5.30 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $184.36 | 7.8 | 23.74 | Analyst | high |
| PEG | 5Y | $102.15 | 28.7 | 3.56 | Analyst | high |
| Own P/E history | 5Y | $156.01 | 43.8 | 3.56 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.